SEC Form D private-offering filing
Silo Pharma, Inc.
A new SEC Form D private-offering notice from Sarasota, FL, a $4,000,015 filer-stated offering target in Biotech. The source filing is one click away.
Publicly traded developmental stage biopharmaceutical company developing therapeutics for PTSD, stress induced anxiety, fibromyalgia and other CNS conditions, including an intranasal PTSD treatment and a ketamine loaded implant for chronic pain.
Filed 2026-07-14Filed to raise $4,000,015First money in 2026-07-09Raised so far $4,000,015HQ (as filed) Sarasota, FLSector Biotech ✓Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified silopharma.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.